INCY vs WT · P/E 14, rev $4.24B vs P/E 44, rev $427.7M
Incyte Corporation (INCY) versus WisdomTree Inc. (WT) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
WisdomTree Inc. (WT) is a asset management company listed on NYSE.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported WT revenue for 2024-12-31 was $427.7M. Net income was $66.7M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. WT currently screens at market cap $2.78B and trailing P/E 44.3.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. WT currently screens at market cap $2.78B and trailing P/E 44.3.
Not investment advice. Open the INCY and WT stock pages for the full models.
Not investment advice.